TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
ICLR

ICON PLC

Healthcare · Diagnostics & Research

161.90$ -4.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios ICLR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
18.7 19.6 16.2 21.9 21.9 25.0 31.7 137.6 31.7 38.2 22.0 62.7
2.1 3.0 2.5 3.5 2.7 3.3 3.7 3.8 2.1 2.9 2.1 1.7
3.4 6.1 4.5 5.0 5.1 5.8 5.6 2.6 1.9 2.5 1.8 1.6
2.5 3.3 2.8 3.7 2.8 3.3 3.5 4.7 2.6 3.3 2.5 2.1
14.0 15.2 12.1 16.1 16.3 17.3 20.3 34.9 14.5 17.6 13.0 20.9
23.5 20.4 19.6 126.4 32.8 25.9 19.1 28.7 38.0 23.0 15.6 16.7
4.3% 4.9% 5.1% 0.8% 3.0% 3.9% 5.2% 3.5% 2.6% 4.4% 6.4% 6.0%
Margins
39.9% 42.3% 42.3% 41.3% 29.6% 29.6% 28.9% 27.5% 28.6% 29.6% 29.4% 26.4%
13.5% 17.9% 18.7% 19.2% 14.4% 15.4% 14.0% 6.9% 10.3% 11.8% 13.3% 12.3%
11.5% 15.2% 15.7% 16.0% 12.4% 13.3% 11.7% 2.8% 6.5% 7.5% 9.6% 2.8%
9.1% 14.6% 13.0% 2.8% 8.3% 12.9% 19.4% 13.4% 5.4% 12.6% 13.5% 10.4%
Returns
18.2% 31.3% 27.7% 22.9% 23.3% 23.1% 17.7% 1.9% 5.9% 6.6% 8.3% 2.5%
11.3% 13.9% 14.4% 12.9% 13.5% 12.9% 9.5% 0.9% 2.9% 3.6% 4.7% 1.4%
Balance Sheet & Debt
483 483 355 323 289 -142 -467 4,734 4,409 3,434 2,924 2,791
1.8 1.4 0.9 0.8 0.6 -0.3 -1.0 6.4 3.1 2.3 1.9 3.4
62.2% 44.5% 51.8% 56.3% 58.1% 55.7% 53.9% 46.4% 49.4% 54.4% 56.4% 56.5%
0.6 0.8 0.6 0.5 0.5 0.2 0.2 0.7 0.6 0.4 0.4 0.4
Per Share
2.73 3.97 4.65 5.13 5.90 6.88 6.15 2.25 6.13 7.40 9.53 2.90
23.81 26.12 29.54 32.05 47.42 51.64 52.50 80.52 93.87 98.17 99.74 104.49
15.05 12.68 16.76 22.42 25.33 29.78 34.72 118.51 103.05 111.71 114.69 116.42
2.17 3.81 3.84 0.89 3.94 6.66 10.20 10.80 5.11 12.34 13.47 10.92

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?